- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.08. | Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex | ||
| 28.08. | Outlook Therapeutics' outlook dims as FDA snubs reformulated Avastin in eye disease-again | ||
| 28.08. | Roche begins building $700M obesity drug manufacturing facility in N.C. | ||
| 28.08. | Fresenius debuts European consortium to pursue bedside CAR-T production | ||
| 27.08. | Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing | ||
| 27.08. | Pfizer, Moderna score restricted FDA approvals for updated mRNA COVID vaccines | ||
| 27.08. | Sanofi contributes to report touting importance of sustainably paid community health workers | ||
| 27.08. | Indivior slims headcount, weighs Opvee divesture in first phase of multiyear restructuring plan | ||
| 27.08. | RemeGen and Vor score again with telitacicept, this time in IgA nephropathy | ||
| 27.08. | Facing pressure from Novartis, Eli Lilly trots out Verzenio patient survival win in early breast cancer | ||
| 27.08. | Amylyx axes rare disease program after Relyvrio fails to beat placebo | ||
| 27.08. | Massachusetts' biopharma hotbed shed R&D, manufacturing workers in '24 as new threats now come to the fore | ||
| 27.08. | C is for check-up: Phreesia brings Sesame Street to patient intake platform | ||
| 26.08. | Akeso, Summit's PD-1xVEGF drug meets overall survival goal for the first time in a lung cancer trial | ||
| 26.08. | Sanofi snags BioMarin leader to take on CMO role 8 months after Berger's exit | ||
| 26.08. | Pfizer lays off 100 workers at former Seagen HQ in Seattle area | ||
| 26.08. | Bayer plugs $43M into Veracruz API site amid sweeping expansion drive in Mexico | ||
| 26.08. | Nusano debuts radioisotope production plant in Salt Lake City amid industry's supply squeeze | ||
| 25.08. | With late-stage trial win, Argenx preps FDA filing to push Vyvgart into broader myasthenia gravis population | ||
| 25.08. | MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal | ||
| 25.08. | FDA does a 180, suspending use of Valneva's chikungunya vaccine | ||
| 25.08. | FDA rolls out daily updates to adverse event dashboard, plans to further 'streamline' system | ||
| 25.08. | BeOne bags $885M upfront in Royalty deal on Amgen's lung cancer drug Imdelltra | ||
| 22.08. | Bavarian Nordic CEO says buyout needed for vaccine specialist to reach its potential | ||
| 22.08. | UK pharma drug price talks break down as industry fails to lower discount rate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .